WatchfulEye
WATCHFULEYE

Isomorphic Labs raises $5B as it looks to take drug candidates to clinical trials

TechCrunch

Isomorphic Labs, the AI drug-discovery company spun out of Google’s DeepMind in 2021, raised $5 billion in a Series C round co-led by Greenoaks and Sequoia Capital, with Andreessen Horowitz and existing investors also participating. The company said its programs have produced positive preclinical results in oncology and immunology and that it plans to use the funding to develop its drug-design engine and expand into more types of medicine as it advances candidates toward clinical trials. Isomorphic has partnerships with Eli Lilly, Novartis and Johnson & Johnson; it did not disclose its new…

moderate: Large private financing; clinical efficacy remains unproven.

That part is in the app.

Open it and the brief is there, with the sources and a place to ask.

Get WatchfulEye Download on the App Store Get it on Google Play
Read the original

Shared from WatchfulEye. The brief is generated for information, not financial advice.